First Trust Advisors
ATNM icon

First Trust Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History

First Trust Advisors’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-51,273
Closed -$406K – 2516
2021
Q2 		$406K Buy
51,273
+15,532
+43% +$122K ﹤0.01% 2320
2021
Q1 		$272K Buy
35,741
+2,869
+9% +$24.4K ﹤0.01% 2339
2020
Q4 		$256K Sell
32,872
-1,481
-4% -$16.1K ﹤0.01% 2246
2020
Q3 		$333K Buy
+34,353
New +$379K ﹤0.01% 2139

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors's ATNM Position: Q3 2021 in Review

First Trust Advisors sold out of Actinium Pharmaceuticals (ATNM) in Q3 2021, closing a stake of 51,273 shares — an estimated $406K sold.

First Trust Advisors first reported a position in ATNM in Q3 2020 and held it in 4 quarters. The position peaked at $406K in Q2 2021. 43 funds tracked by Wall St. Rank hold ATNM as of Q3 2021.

  • First Trust Advisors reported no remaining Actinium Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • First Trust Advisors sold 51,273 Actinium Pharmaceuticals shares in Q3 2021, an estimated $406K.
  • First Trust Advisors first reported a position in Actinium Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • First Trust Advisors's Actinium Pharmaceuticals position peaked at $406K in Q2 2021.
  • 43 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2021.

Based on First Trust Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.